Growth of bifidobacteria and clostridia on human and cow milk saccharides

Anaerobe

Volumn 17, Issue 5, 2011, Pages 223-225

  Rockova, Sarka ^a   Rada, Vojtech ^a   Marsik, Petr ^b   Vlkova, Eva ^a   Bunesova, Vera ^a   Sklenar, Jan ^c   Splichal, Igor ^c  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Bifidobacteria; Clostridia; Cow milk; Human milk; Milk saccharides

Indexed keywords

CARBOHYDRATE; LACTOSE; LYSOZYME; OLIGOSACCHARIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BREAST MILK; CARBON SOURCE; CLOSTRIDIA; CLOSTRIDIUM BUTYRICUM; CONTROLLED STUDY; MILK; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL LOAD; BIFIDOBACTERIUM; CLOSTRIDIUM BUTYRICUM; CULTURE MEDIA; FECES; HUMANS; LACTOSE; MILK; MILK, HUMAN; OLIGOSACCHARIDES;

BACTERIA (MICROORGANISMS); CLOSTRIDIA;

EID: 80053121951     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.07.009     Document Type: Article

References (23)

1. Fallani M., Young D., Scott J., Norin E., Amarri S., Adam R., et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. Journal of Pediatric Gastroenterology and Nutrition 2010, 51:77-84. other members of the INFABIO Team.
2. Gronlund M., Lehtonen P., Eerola E., Kero P. Faecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. Journal of Pediatric Gastroenterology and Nutrition 1999, 28:19-25.
3. Ferraris L., Butel M.-J., Aires J. Antimicrobial susceptibility and resistance determinants of Clostridium butyricum isolates from preterm infants. International Journal of Antimicrobial Agents 2010, 36:420-423.
4. Cato E.P., George W.L., Finegold S.M. Genus Clostridium Prazmowski 1880, 23AL. Bergey's Manual of Systematic Bacteriology 1986, vol. 2:1141-1200. Edited by International Journal of Systematic and Evolutionary Microbiology 51 965 Tamburini E and others Sneath PHA, Mair NS, Sharpe ME, Holt. Baltimore JG: Williams & Wilkins.
5. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L.M., Hatheway C.L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. Journal of Infectious Diseases 1986, 154:207-211.
6. Obladen M. Necrotizing enterocolitis-150 years of fruitless search for the cause. Neonatology 2009, 96:203-210.
7. Vlková E., Nevoral J., Jenčiková B., Kopečný J., Godefrooij J., Trojanová I., et al. Detection of infant faecal bifidobacteria by enzymatic methods. Journal of Microbiological Methods 2005, 60:365-373.
8. Roberfroid M. Prebiotics: the concept revisited. The Journal of Nutrition 2007, 137:830-837.
9. Boehm G., Jelinek J., Stahl B., van Laere K., Knol J., Fanaro S., et al. Prebiotics in infant formulas. Journal of Clinical Gastroenterology 2004, 38(Suppl. 2):76-79.
10. Euler A.R., Mitchell D.K., Kline R., Pickering L.K. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. Journal of Pediatric Gastroenterology and Nutrition 2005, 40:157-164.
11. Rada V., Nevoral J., Trojanová I., Tománková E., Smehilová M., Killer J. Growth of infant faecal bifidobacteria and clostridia on prebiotic oligosaccharides in in vitro conditions. Anaerobe 2008, 14:205-208.
12. Rada V., Šplíchal I., Ročková Š, Grmanová M., Vlková E. Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains. Biotechnology Letters 2010, 32:451-455.
13. Osserman E.F., Lawlor D.P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. The Journal of Experimental Medicine 1966, 124:921-952.
14. Packard V.S. Human milk: extraction, processing, and storage. Human milk and infant formula 1982, 176-186. Academic Press, Inc., New York. G.F. Stewart, B.S. Schweigert, J. Hawthorn (Eds.).
15. Ewaschuk J.B., Unger S., O'Connor D.L., Stone D., Harvey S., Clandinin M.T., et al. Journal of Perinatology 2011, 10.1038/jp.2010.209.
16. Rada V., Petr J. A new selective medium for the isolation of glucose nonfermenting bifidobacteria from hen caeca. Journal of Microbiological Methods 2000, 43:127-132.
17. Rockova S., Nevoral J., Rada V., Marsik P., Sklenar J., Hinkova A., et al. Factors affecting the growth of bifidobacteria in human milk. International Dairy Journal 2011, 21:504-508.
18. Lönnerdal B. Nutritional and physiological significance of human milk proteins. The American Journal of Clinical Nutrition 2003, 77:1537-1543.
19. Field C.J. The immunological components of human milk and their effect on immune development in infants. Journal of Nutrition 2005, 135:1-4.
20. Paramasivam K., Michie C., Opara E., Jewell A.P. Human breast milk immunology: a review. International Journal of Fertility 2006, 51:208-217.
21. Ogundele M.O. Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significance. Mediators of Inflammation 1999, 8:69-75.
22. Clare D.A., Catignani G.L., Swaisgood H.E. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Current Pharmaceutical Design 2003, 9:1239-1255.
23. Scardovi V. Genus Bifidobacterium Orla-Jensen. 1924, 472. Bergey's manual of systematic bacteriology 1986, vol. 2:1418-1434. 349, Williams and Wilkins, 350 Baltimore, MD, USA. N.R. Krieg, J.G. Holt (Eds.).